Cardiovascular Diseases
May 29, 2024
From Lab to Lifesaver: Advancing Artificial Blood Vessels for Healthier Tomorrows
Artificial blood vessels are at the forefront of medical innovation, offering a lifeline to millions worldwide. With advancements in bioengineering, these synthetic conduits are shaping a new era in healthcare, promising solutions to cardiovascular diseases and beyond. Artificial blood vessels represent a revolu...
Read More...
Dec 13, 2023
Understanding the Growth and the Evolving Market Dynamics of Cardiac Rhythm Management Devices
Globally, cardiovascular diseases (CVDs) stand as the primary cause of mortality, claiming an estimated 17.9 million lives in 2019 alone, which accounted for 32% of all global deaths. Among these fatalities, a staggering 85% were attributed to heart attacks and strokes. Within the spectrum of noncommunicable diseas...
Read More...
Feb 15, 2023
Pacemakers: Analyzing the Market Dynamics and Major Developments
Over the past few decades, the prevalence of cardiovascular diseases has grown significantly, leading to very high mortality and morbidity worldwide. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other condition...
Read More...
Nov 17, 2022
Medtronic Launches Infusion Set for Insulin Pumps; Penumbra’s Virtual Reality-Based Rehabilitation System; FDA Approval to Genesis’s Chocolate Touch® Drug-coated Balloon PTA Catheter; FDA Nod to AEYE’s AI-based Autonomous Screening; Alpheus Medical Treats First High-Grade Glioma Brain Cancer Patient with its Proprietary Platform; Karidum’s Next Generation Globe® Pulsed Field System
Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in the US On November 15, 2022, Medtronic plc, a global leader in healthcare technology, announced the US launch of the Medtronic Extended infusion set, the first and only infusion set labeled for up to ...
Read More...
Sep 01, 2022
Miracor Medical’s Picso Pivotal Study; Medtronic’s Extravascular ICD; Galaxy Medical’s CENTAURI Pulsed Electric Field System; UltraSight’s Novel Cardiac AI Technology; Oticon Launched the World’s Smallest Hearing Aid; Medtronic Completes Acquisition of Affera
FDA Approved IDE for Picso® Pivotal Study of Miracor Medical On August 23, 2022, Miracor Medical SA, a provider of innovative solutions for the treatment of severe cardiac diseases, announced that the FDA has approved an Investigational Device Exemption (IDE), allowing the company to begin a pivotal study with i...
Read More...
Jul 06, 2022
Understanding How Cardiac Devices are Aiding in Treatment and Prevention of Heart Disease
Cardiovascular diseases (CVD) remain the world's leading cause of death, killing an estimated 17.9 million people each year, according to data from the World Health Organization (2021). It is the main cause of disease burden in the world. CVD continues its years-long increase in almost all countries outside the hig...
Read More...
Jun 23, 2022
CE Mark to Ibex’s Gastric Cancer Detection System; Senseonics’s Eversense E3 Continuous Glucose Monitoring System; NEUSPERA’s NUVELLA SYSTEM; Conformal Medical Initiates CONFORM Pivotal Trial; Meridian Launches New qPCR Master Mixes for Stool Samples; Sentinel Diagnostics Launches SENTiFIT 800
Conformal Medical Announces Launch of CONFORM Pivotal Trial On June 17, 2022, Conformal Medical Inc, is a medical device company manufacturing devices to avoid strokes in patients with non-valvular atrial fibrillation and developing next-generation LAAO technology. Its exclusive technology is intended to make le...
Read More...
Jun 14, 2022
GSK’s RSV Vaccine Clears Phase III Test in Adults; Roche’s Tecentriq for Adjuvant NSCLC; Owkin Bags $ 180 million from BMS; EU Approves Roche’s Mosunetuzumab; Dostarlimab Elicits Clinical Complete Response in dMMR Rectal Cancer; FDA Backs Bluebird’s CALD Gene Therapy; Takeda’s Dengue Fever Vaccine TAK-003; FDA Approves Dupilumab
GSK Starts Preparations for Regulatory Filings as RSV Vaccine Clears Phase III Test in Adults GSK plans to initiate preparation for regulatory submissions for its respiratory syncytial virus (RSV) vaccine after the vaccine performed well in the much-anticipated AReSVi 006 trial in individuals aged 60 and above.&...
Read More...
Apr 28, 2022
MEDIT’s i700 Intraoral Scanner; Phantom Neuro and Blackrock’s Next-Generation Assistive Devices; Fresenius Medical’s Versi PD Cycler System; Franklin Mountain’s Dual Lumen Catheter for Cardiac Applications; Bioretec’s Bioresorbable Implant; Vectorious’s VECTOR-HF II Study
MEDIT Announces Launch of i700 Intraoral Scanner On April 20, 2022, based on the success of i700 intraoral scanner, MEDIT Corp launched the all new i700 wireless intraoral scanner is light, fast, accurate, and now – wire-free. i700 wireless is a lightweight, wire-free device that offers a smooth and qui...
Read More...
Feb 04, 2022
Major Drugs Decisions for Cardiovascular Diseases to Watch Through 2022
The discovery of new classes of highly effective drug therapy for prevalent kinds of cardiovascular diseases has witnessed spectacular success in recent decades. The widespread use of these cardiovascular drugs, combined with smoking cessation and nonpharmacological therapy, is thought to be responsible for decreas...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
